The difference remained significant when analysis was done according to cancer subtype for CD4+CD45RChigh T cells frequency, while CD8+CD45RChigh T cell frequency was no longer different between patients with or without solid cancer/PLTD (S2 Table). This evidence concerns the gene CD8A and cancer.